District Of Columbia is currently home to 862 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Washington, Washington, D.C., Washington DC and Washington, Dc. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients
NCT04911465
Recruiting
This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolled in the study and data will be collected for 12-24 hours based on the patient's hemodynamic status. The device collects data via a pulse oximeter probe. No treatment decisions will be made based on the values of the on the CRI tablet. Data will be retrospectively reviewed to determine if any trends... Read More
Gender:
All
Ages:
Between 31 days and 26 years
Trial Updated:
09/25/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Trauma
Register for Updates
Reshaping Postpartum Follow-up
NCT06054841
Recruiting
The aim of this study is to evaluate the impact of personalized postpartum follow-up cards on completion of postpartum health related tasks. The intervention will consist of a card given to patients at time of discharge. One side of the card will list the patient's name and a list of recommended postpartum follow-up appointments based on their diagnoses at the time of discharge. Participants will be randomized to this intervention or the control group, which will consist of standard education ro... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/19/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Hypertension in Pregnancy, Gestational Diabetes, Cervical Dysplasia
Register for Updates
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT04786574
Recruiting
The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney disease (ARPKD)
Gender:
All
Ages:
Between 28 days and 12 weeks
Trial Updated:
09/14/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Register for Updates
SNS and PrEP Initiation and Adherence in Black SMM
NCT05499962
Recruiting
Specific Aim 1. Conduct 18 focus groups among Black gay, bisexual and other sexual minority men (SMM; n=72-90) in the Washington, DC area of different age groups (18-24, 25-34, 35+) and various pre-exposure prophylaxis (PrEP) use profiles (i.e., PrEP naïve, current PrEP users, and discontinued PrEP; two per age-group and PrEP use profile) to understand intervention feasibility, acceptability and appropriateness, how the intervention can address experienced and perceived socio-structural barriers... Read More
Gender:
Male
Ages:
18 years and above
Trial Updated:
09/13/2023
Locations: Us Helping Us, People Into Living, Inc., Washington, District of Columbia
Conditions: HIV
Register for Updates
Evaluation of The Food Allergy Mastery Program
NCT06034678
Recruiting
The proposed research project will evaluate a novel behavioral intervention that promotes early adolescent food allergy self-management and adjustment through 1) food allergy education, 2) problem-solving, communication, assertiveness, and anxiety management skill building, and 3) peer support.
Gender:
All
Ages:
Between 10 years and 14 years
Trial Updated:
09/05/2023
Locations: Childrens' National Hospital, Washington, District of Columbia
Conditions: Food Allergy in Children
Register for Updates
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107
Recruiting
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
09/05/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis
Register for Updates
Group Visits for High Risk Type 1 Diabetes (T1D)
NCT05431686
Recruiting
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Gender:
All
Ages:
8 years and above
Trial Updated:
08/31/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Type 1 Diabetes
Register for Updates
Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)
NCT05310227
Recruiting
The goal of this study is to examine the effects of the Remote Electrical Neuromodulation (REN) device on adolescents ages 12-17 who have been diagnosed with New Daily Persistent Headache (NDPH). Pediatric patients with a diagnosis of new daily persistent headache are typically resistant to standard pharmacologic treatments and often experience systemic side effects related to medications; thus, REN offers the potential for an exciting new treatment option for patients with refractory headache d... Read More
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
08/31/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: New Daily Persistent Headache (NDPH)
Register for Updates
AltaValve Early Feasibility Study Protocol
NCT03997305
Recruiting
Prospective, single-arm, multicenter study to evaluate the safety and performance of the AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: MedStar Washington Hospital, Washington, District of Columbia
Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence
Register for Updates
Transform CV Risk in Diabetes
NCT05948969
Recruiting
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Gender:
All
Ages:
18 years and above
Trial Updated:
07/13/2023
Locations: Multiple sites nationwide, Washington, District of Columbia
Conditions: Type 2 Diabetes
Register for Updates
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158
Recruiting
Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
06/27/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Diabetic Foot Ulcer
Register for Updates
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272
Recruiting
In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/25/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Aortic Valve Replacement
Register for Updates